News
A federal appeals court in San Francisco has heard arguments on whether the Trump administration should return control of ...
2h
Zacks Investment Research on MSNSlowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
A federal appeals court in San Francisco is set to hear arguments on whether the Trump administration should return control ...
Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- ...
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results